Naming ability assessment in neurocognitive disorders: a clinician’s perspective

Abstract

Background Detecting impaired naming capacity is valuable in diagnosing neurocognitive disorders (ND). A. clinical practice- oriented overview of naming tests validated in ND is not available yet. Here, features of naming tests with validated utility in ND which are open access or available for purchase are succinctly presented and compared. Methods Searches were carried out across Pubmed, Medline and Google Scholar. Additional studies were identified by searching reference lists. Only peer-reviewed journal articles were eligible. A narrative- and tabullar synthesis was used to summarize different aspects of the naming assessment instruments used in patients with ND such as stimuli type, administration time, assessment parameters and accessibility. Based on computational word frequency calculations, the tests were compared in terms of the average frequency of their linguistic content. Results Twelve naming tests, relying either on visual or auditory stimuli have been validated in ND. Their content and administration time vary between three and 60 items and one and 20 minutes, respectively. The average frequency of the words of each considered test was two or lower, pointing to low frequency of most items. In all but one test, scoring systems are exclusively based on correctly named items. Seven instruments are open access and four are available in more than one language. Conclusions Gaining insights into naming tests’ characteristics may catalyze the wide incorporation of those with short administration time but high diagnostic accuracy into the diagnostic workup of ND at primary healthcare and of extensive, visual or auditory ones into the diagnostic endeavors of memory clinics, as well as of secondary and tertiary brain healthcare settings.

Benzodiazepine Consumption, Functionality, Cognition, and Somnolence in Older Adults at a Tertiary Care Psychiatric Hospital in Mexico City

“…Higher education levels were observed in BZD users who scored above 24 on MoCA, comparable to the results reported by Guo et al [ 26 ]. An inverse correlation was found between diazepam equivalent dose and performance on the naming subtest of MoCA, suggesting that higher doses may impair linguistic and perceptual-visual skills, an early symptom in Alzheimer’s disease [ 29 , 30 ].…”

Item-Level Scores on the Boston Naming Test as an Independent Predictor of Perirhinal Volume in Individuals with Mild Cognitive Impairment

“…Successful naming of BNT items depends on a set of cognitive abilities, including sensorimotor functioning (i.e., visual perception and phono-articulatory skills), visual recognition, SM, and lexical access [56]. Although it is not possible to link incorrectly named items to deficits or setbacks in any specific function from the above list, people who are neurologically healthy and individuals diagnosed with MCI typically do not have any sensorimotor difficulties.…”

Picture naming test through the prism of cognitive neuroscience and linguistics: adapting the test for cerebellar tumor survivors—or pouring new wine in old sacks?

“…Once motor programming starts, effects of word length (syllable / phonemic) set in ( Heikkola et al, 2021 ). Several additional variables might influence lexical retrieval too: namely, phonological neighborhood density ( Arutiunian and Lopukhina, 2018 ), type of object (natural or artificial), body-object interaction (BOI) and manipulability ( Georgiou et al, 2022 )—the latter two fitting the paradigm of grounded cognition.…”